From tendon and ligament models to gut mucosal research and angiogenesis studies, the peptide remains a valuable tool for exploring how the body responds to injury, stress, and tissue repair
The safety profile appears similar to other peptide medications in the metabolic class
NCT04184622
Research shows it interacts with dopamine, serotonin, GABA, and nitric oxide systems
Gastrointestinal Cytoprotection In its original gastric biology context, BPC-157 promotes mucosal integrity through prostaglandin-independent mechanisms, modulates enteric neuron and glial cell activity, counteracts NSAID-induced intestinal permeability, and demonstrates organoprotective activity across the alimentary canal from oesophagus to colon in a range of injury models including ethanol, aspirin, and restraint stress-induced lesions
How these two effects interact when combined has not been studied, so the net effect on blood sugar is unknown